{"id":"131-i-tm-601","safety":{"commonSideEffects":[{"rate":"20-40%","effect":"Fatigue"},{"rate":"10-30%","effect":"Nausea"},{"rate":"5-20%","effect":"Vomiting"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by emitting alpha particles that damage the DNA of cancer cells, leading to cell death. This approach allows for a more targeted and less toxic treatment compared to traditional chemotherapy.","oneSentence":"131-I-TM-601 is a targeted alpha-particle therapy that selectively targets and destroys cancer cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:24:48.996Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Relapsed or refractory multiple myeloma"}]},"trialDetails":[{"nctId":"NCT00114309","phase":"PHASE2","title":"131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma","status":"UNKNOWN","sponsor":"TransMolecular","startDate":"2004-11","conditions":"Malignant Glioma, Glioblastoma Multiforme, GBM","enrollment":66},{"nctId":"NCT00379132","phase":"PHASE1","title":"131-I-TM-601 Study in Adults With Solid Tumors","status":"COMPLETED","sponsor":"TransMolecular","startDate":"2006-08","conditions":"Breast Cancer, Non-Small Cell Lung Cancer, Melanoma","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["chlorotoxin"],"phase":"phase_2","status":"active","brandName":"131-I-TM-601","genericName":"131-I-TM-601","companyName":"TransMolecular","companyId":"transmolecular","modality":"Small molecule","firstApprovalDate":"","aiSummary":"131-I-TM-601 is a targeted alpha-particle therapy that selectively targets and destroys cancer cells. Used for Relapsed or refractory multiple myeloma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}